US/UK/Canada

Share

Links

Quotes

In the past, resistance mechanisms were usually thought of as static. Our study demonstrates, conversely, that a binary designation of resistance may oversimplify cancer’s true biology. These genetic mutations can fluctuate over time, and some patients can harbor more than one mutation.
Zofia Piotrowska, MD, lead author of the study
In an era where cancer treatment is increasingly personalized to the biology of each individual patient, our findings highlight the importance of molecular testing and the need for improved, noninvasive methods for serial testing.
Zofia Piotrowska, MD
In the past year, the Vice President’s moonshot initiative has brought critical attention to the need for greater collaboration and innovation in cancer research, and we are invigorated at the prospect of radiation oncology being an instrumental component of future progress. Moving forward, we must maintain the focus on advancing both the science and practice of cancer care while aligning our efforts to move Congress to authorize the $700 million requested by the President for cancer research initiatives. Substantial, predictable financial support is essential to sustain the fight to eradicate cancer.
Bruce G. Haffty, MD, FASTRO, past Chair of ASTRO’s Board of Directors
The goal of ASTRO’s 2016 Annual Meeting is to highlight the latest scientific and technological advances while emphasizing the importance of radiation oncology in providing value to cancer patients through cure and palliation.
ASTRO President David C. Beyer, MD, FASTRO
Pick a time period -
Tags ( Active)

ASTRO applauds bipartisan legislation to repeal the SGR and urges swift passage to strengthen Medicare and to protect patient care

Nearly 100 ASTRO members advocated in Washington for a permanent fix to the flawed SGR formulaFairfax, Va., March 25, 2015 – The American Society for Radiation Oncology (ASTRO) commends Congressional leadership for introduction of the “Medicare Access and CHIP Reauthorization Act” (H.R. 2) and urges swift passage during votes in the House and Senate later this week. ASTRO also held its 12th Annual Advocacy Day efforts yesterday, with 97 ASTRO members convening in Washington, D.C., for more than 130 meetings with Congressional leaders from their home districts. In addition to this on-the-

AIM applauds AARP’s support of closing physician self-referral loophole

The Alliance for Integrity in Medicare (AIM) — a broad coalition of medical specialty, laboratory, radiation oncology and medical imaging groups committed to ending the practice of inappropriate physician self-referral — strongly commends the letter sent by the AARP to Rep. Jackie Speier (D-Calif.)  on December 11, 2014.  AIM applauds AARP for defending patients who are at risk of receiving unnecessary care caused by the abusive, profit-

ASTRO’s 11th annual Advocacy Day featured meetings with more than 150 members of Congress

More than 75 ASTRO members pushed for key radiation oncology initiatives to benefit patients, physicians and researchersFairfax, Va., May 8, 2014—During the American Society for Radiation Oncology’s (ASTRO’s) 11thannual Advocacy Day in Washington, D.C. on May 5-6, 2014, more than 75 ASTRO members met with more than 150 congressional members from their 32 home states. Attendees, including radiation oncologists, nurses, administrators and a record of 24 radiation oncology residents, urged Congress to close the self-referral loophole, to stabilize Medicare physician payments, to provide

ASTRO applauds new CBO estimate demonstrating that ending self-referral abuse would save Medicare more than $3 billion

Fairfax, Va. April 17, 2014 — The Congressional Budget Office (CBO) today released a new assessment of the significant costs associated with physician self-referral abuse, estimating that closing the self-referral law’s loophole would save Medicare approximately $3.4 billion over a 10-year budget window. CBO’s new savings estimate—nearly double its previous estimate—adds additional weight to the existing mountain of evidence that the in-office ancillary services (IOAS) loophole results in potentially inappropriate patient care and substantial costs to the Medicare program. CBO’s savings

Joint Statement from the Alliance for Integrity in Medicare Applauding IOAS Reform Proposal in the President’s FY 2015 Budget

The Alliance for Integrity in Medicare (AIM), a broad coalition of medical specialty, laboratory, radiation oncology, and medical imaging groups committed to ending the practice of inappropriate physician self-referral, is extremely pleased that President Obama’s FY 2015 Budget , released today, recommends the exclusion of anatomic pathology, advanced diagnostic imaging, therapy services, including physical therapy, and radiation therapy from the In-Office Ancillary Services (IOAS) exception. AIM has long supported additional

ASTRO applauds today’s Congressional proposal to repeal and replace the SGR

Fairfax, Va., February 6, 2014 — The American Society for Radiation Oncology (ASTRO) supports today’s bipartisan proposal to repeal and replace the Medicare physician payment formula. The proposal , announced by the leaders of the Senate Finance and House Ways & Means and Energy & Commerce Committees, repeals the Medicare sustainable growth rate (SGR) formula; provides a 0.5 percent increase each year for five years; consolidates three existing quality programs into one quality incentive

New study in NEJM exposes overuse of radiation therapy services when urologists profit through self-referral

IMRT use is 2 ½ times greater when self-referral’s financial incentives are involvedA comprehensive review of Medicare claims for more than 45,000 patients from 2005 through 2010 found that nearly all of the 146 percent increase in intensity- modulated radiation therapy (IMRT) for prostate cancer among urologists with an ownership interest in the treatment was due to self-referral, according to new research, “Urologists’ Use of Intensity-Modulated Radiation Therapy for Prostate Cancer,” released today in The New England Journal of Medicine (NEJM) for its October 24, 2013 issue. This study

New study in NEJM exposes overuse of radiation therapy services when urologists profit in self-referral practices

WHAT:          Dr. Jean Mitchell unveils her new study, “Urologists’ Use of Intensity Modulated Radiation Therapy for Prostate Cancer,” detailing physician self-referral abuse, to be published October 24, 2013, in The New England Journal of Medicine. WHEN:          Thursday, October 24, 2013, 12:30 p.m. – 1:30 p.m. ET WHERE:        National Press Club, First Amendment Room                        529 14th Street NW, Washington, DC 20045 WHO:             Jean M. Mitchell, PhD, Economist and Professor, McCourt School of Public Policy at Georgetown University, specializing in health

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media